Pacira Pharmaceuticals (PCRX) PT Raised to $72 at BMO Capital

February 26, 2021 9:45 AM EST
Get Alerts PCRX Hot Sheet
Price: $67.95 -0.44%

Rating Summary:
    14 Buy, 13 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 19 | Down: 18 | New: 47
Trade Now! 
Join SI Premium – FREE
BMO Capital analyst Gary Nachman raised the price target on Pacira Pharmaceuticals (NASDAQ: PCRX) to $72.00 (from $65.00) while maintaining a Market Perform rating.

You May Also Be Interested In

Related Categories

Analyst PT Change